Skip to main content

News and blog posts

23
Sep 2020

Multiple endoscopy-related procedure codes to be released in Germany in 2021

In mid-August 2020, the German Federal Institute for Drugs and Medical Devices (BfArM) published the preliminary 2021 version of OPS procedure coding nomenclature. Numerous content updates and new procedure codes inclusion concern the chapters 1 “Diagnostic measures,” 5 “Operations,” and 8 “Non-operative therapeutic measures.” The list of new endoscopy-related procedure codes added under the respective OPS sub-chapters of chapters 1 and 5 is provided below:
22
Sep 2020

Research project to analyze factors besides clinical evidence, influencing reimbursement decisions or the hospital benefit catalog 2010-2020, started in Austria

Earlier in September 2020, the Austrian Institute for Health Technology Assessment (AIHTA) released a synopsis of the ongoing research project “Reimbursement decisions for medical procedures in Austria: An analysis of factors – besides clinical evidence – influencing reimbursement decisions for the hospital benefit catalog 2010-2020.”
16
Sep 2020

Mini-HTA of MitraClip released in Norway

In September 2020, a completed mini-method assessment for the MitraClip for percutaneous mitral valve repair was issued within the New Methods framework. The Oslo University Hospital carried out the evaluation. The method was recommended for routine use in hospitals.
14
Sep 2020

MTRC developed the first issue of HTA Alerts

The first issue of HTA Alerts included 186 reports from European organizations only. This issue included reports, published or initiated from the 1st of August 2020, and ongoing reports. The most common technological fields were cardiovascular, gastroenterology, in-vitro diagnostics, men's health, neuromodulation, and orthopedics. Contact us if you want to receive a sample alert and to learn more about the service.
11
Sep 2020

Decisions about intra-DRG reimbursement for medical devices in France in July 2020

The French National Authority for Health (HAS) released new decisions about intra-DRG reimbursement of medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in July 2020. Decisions concern cardiac sutureless valve bioprostheses and implantable devices for the treatment of urinary incontinence.